Skip to main content
drug protocol number
D910VC00001
drug sponsor
AstraZeneca
drug study
Lenvatinib (Lenvima) + Durvalumab (Imfinzi) + Tremelimumab (Imjudo)
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh) ,King Abdulaziz Medical City NG (Jeddah), King Fahad Specialist Hospital (Dammam), King Abdulaziz Medical City NG (Riyadh)
drug status
Ongoing
drug phase